203 related articles for article (PubMed ID: 35093305)
1. ZEB1 induces ROS generation through directly promoting MCT4 transcription to facilitate breast cancer.
Han X; Long Y; Duan X; Liu Z; Hu X; Zhou J; Li N; Wang Y; Qin J
Exp Cell Res; 2022 Mar; 412(2):113044. PubMed ID: 35093305
[TBL] [Abstract][Full Text] [Related]
2. ZEB1 directly inhibits GPX4 transcription contributing to ROS accumulation in breast cancer cells.
Han X; Duan X; Liu Z; Long Y; Liu C; Zhou J; Li N; Qin J; Wang Y
Breast Cancer Res Treat; 2021 Jul; 188(2):329-342. PubMed ID: 34169392
[TBL] [Abstract][Full Text] [Related]
3. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
4. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.
Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW
Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
6. Human Schlafen 5 regulates reversible epithelial and mesenchymal transitions in breast cancer by suppression of ZEB1 transcription.
Wan G; Zhu J; Gu X; Yang Y; Liu Y; Wang Z; Zhao Y; Wu H; Huang G; Lu C
Br J Cancer; 2020 Aug; 123(4):633-643. PubMed ID: 32488136
[TBL] [Abstract][Full Text] [Related]
7. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
[TBL] [Abstract][Full Text] [Related]
8. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
9. ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer.
Zhang J; Zhou C; Jiang H; Liang L; Shi W; Zhang Q; Sun P; Xiang R; Wang Y; Yang S
Cell Death Dis; 2017 Apr; 8(4):e2732. PubMed ID: 28383555
[TBL] [Abstract][Full Text] [Related]
10. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
11. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
12. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
13. UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis.
Shi D; Guo L; Sun X; Shang M; Meng D; Zhou X; Liu X; Zhao Y; Li J
Sci Rep; 2020 Apr; 10(1):6657. PubMed ID: 32313093
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.
Wu HT; Zhong HT; Li GW; Shen JX; Ye QQ; Zhang ML; Liu J
J Transl Med; 2020 Feb; 18(1):51. PubMed ID: 32014049
[TBL] [Abstract][Full Text] [Related]
15. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
16. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
Sinh ND; Endo K; Miyazawa K; Saitoh M
Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA AFAP1-AS1 promoting epithelial-mesenchymal transition of endometriosis is correlated with transcription factor ZEB1.
Lin D; Huang Q; Wu R; Dai S; Huang Z; Ren L; Huang S; Chen Q
Am J Reprod Immunol; 2019 Jan; 81(1):e13074. PubMed ID: 30506548
[TBL] [Abstract][Full Text] [Related]
18. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
19. PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial-Mesenchymal Transition in Breast Cancer.
Hou P; Li L; Chen F; Chen Y; Liu H; Li J; Bai J; Zheng J
Cancer Res; 2018 Jan; 78(2):387-398. PubMed ID: 29187406
[TBL] [Abstract][Full Text] [Related]
20. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
